PHARMACEUTICS 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “9th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” (PHARMACEUTICS 2023) Hybrid Event scheduled during June 12-13, 2023 | Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at [email protected] or call + 1 (702) 988 2320.
9th Edition of Global Conference on
Pharmaceutics and Novel Drug Delivery Systems
June 12-13, 2023 | Rome, Italy
Biosimilar Market
A biotherapeutic product that is highly comparable to a reference biologic medication is referred to as a biosimilar, also known as a follow-on biologic. It has a complicated molecular structure and is made from living organisms or cells. When a biologic drug's patent expires, firms must seek approval from regulatory authorities before beginning production of biosimilars. Biosimilars are medicines that are primarily made up of proteins that are structurally and functionally similar to biological pharmaceuticals. By 2020, the overall yearly savings gained from the consistent use of biosimilars in meeting expanding public health consumer needs is expected to exceed USD 100 billion. Biosimilar drugs are becoming increasingly popular as a way to cut healthcare expenses.
- Barriers in Developing Biosimilar Drugs
- Global trends in Biosimilar Drug Market
- Regulatory Constraints
Richard Denk
SKAN AG, Switzerland
Thomas J Webster
Hebei University of Technology, China
Luis Jesus Villarreal Gomez
Autonomous University of Baja California, Mexico
Richard Denk
SKAN AG, Switzerland
Luis Jesus Villarreal Gomez
Autonomous University of Baja California, Mexico
Raphael Mechoulam
The Hebrew University of Jerusalem, Israel
Pierfrancesco Morganti
Academy of History of Healthcare Art, ItalySubmit your abstract Today
Title : Manufacturing outlook on Cell and Gene and Aseptic Processing according the EU GMP
Richard Denk, SKAN AG, Switzerland
Title : Antimicrobial electrospun fibrous scaffolds and their potential application as skin drug delivery systems
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Limiting factors in implementing pharmacovigilance principles in the elderly
Jasleen Nagi, Imperial College London, United Kingdom
Title : Micellar Biomimetic Chromatography in studies of pesticides’ mobility in soil and bioconcentration in aquatic organisms – are pesticides’ bioconcentration factors, soil-water partition coefficients and human placenta permeability interrelated?
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : Digital health: Education in clinical pharmacy and implementation in practice
Aysu selcuk, Ankara University, Turkey
Title : The Role of Non-Antibiotic Drugs on the Development of Antibiotic Resistance
Mujde Eryilmaz, Ankara University, Turkey